A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses.

MLA

Chenguang Shen, et al. “A Multimechanistic Antibody Targeting the Receptor Binding Site Potently Cross-Protects against Influenza B Viruses.” Science Translational Medicine, vol. 9, no. 412, Oct. 2017, pp. 1–12. EBSCOhost, https://doi.org/10.1126/scitranslmed.aam5752.

APA

Chenguang Shen, Junyu Chen, Rui Li, Mengya Zhang, Guosong Wang, Stegalkina, S., Limin Zhang, Jing Chen, Jianli Cao, Xingjian Bi, Anderson, S. F., Alefantis, T., Minwei Zhang, Xiaoyang Cai, Kunyu Yang, Qingbing Zheng, Mujing Fang, Hai Yu, Wenxin Luo, & Zizheng Zheng. (2017). A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses. Science Translational Medicine, 9(412), 1–12. https://doi.org/10.1126/scitranslmed.aam5752

Chicago

Chenguang Shen, Junyu Chen, Rui Li, Mengya Zhang, Guosong Wang, Svetlana Stegalkina, Limin Zhang, et al. 2017. “A Multimechanistic Antibody Targeting the Receptor Binding Site Potently Cross-Protects against Influenza B Viruses.” Science Translational Medicine 9 (412): 1–12. doi:10.1126/scitranslmed.aam5752.